(MENAFN- 3BL) January 22, 2026 /3BL/ - Medtronic, a global leader in healthcare technology, announced verification study results for its investigational NellcorTM pulse oximetry with Nell-EQTM ...
As the FDA convenes an advisory committee meeting to discuss recent studies showing that many pulse oximeters are less effective when used on patients with darker skin, BioIntelliSense is getting a ...
DENVER, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc. a continuous health monitoring and clinical intelligence company, today announced the launch of its patented, FDA-cleared, pulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results